AMLP | FENY | SHEH | |
Gain YTD | 5.599 | 0.831 | 6.203 |
Net Assets | 10.5B | 1.27B | N/A |
Total Expense Ratio | 0.85 | 0.08 | N/A |
Turnover | 18.00 | 11.00 | N/A |
Yield | 8.03 | 3.30 | N/A |
Fund Existence | 15 years | 12 years | N/A |
AMLP | FENY | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 2 days ago82% | 2 days ago89% |
Momentum ODDS (%) | 2 days ago85% | 2 days ago90% |
MACD ODDS (%) | 2 days ago88% | 2 days ago90% |
TrendWeek ODDS (%) | 2 days ago88% | 2 days ago88% |
TrendMonth ODDS (%) | 2 days ago87% | 2 days ago87% |
Advances ODDS (%) | 2 days ago90% | 2 days ago89% |
Declines ODDS (%) | 14 days ago80% | 8 days ago86% |
BollingerBands ODDS (%) | N/A | 2 days ago88% |
Aroon ODDS (%) | 2 days ago84% | 2 days ago88% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UITB | 46.43 | 0.14 | +0.29% |
VictoryShares Core Intermediate Bond ETF | |||
XTWY | 37.43 | 0.10 | +0.26% |
BondBloxx Bloomberg TwentyYrTrgDuUSTrETF | |||
TLTD | 82.78 | 0.09 | +0.11% |
FlexShares Mstar DevMks exUS FctTilt ETF | |||
CNCR | 9.02 | N/A | N/A |
Range Cancer Therapeutics ETF | |||
CZA | 105.37 | -0.57 | -0.54% |
Invesco Zacks Mid-Cap ETF |
A.I.dvisor indicates that over the last year, FENY has been closely correlated with MGY. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if FENY jumps, then MGY could also see price increases.
Ticker / NAME | Correlation To FENY | 1D Price Change % | ||
---|---|---|---|---|
FENY | 100% | +1.53% | ||
MGY - FENY | 91% Closely correlated | +1.28% | ||
OVV - FENY | 91% Closely correlated | +3.18% | ||
XOM - FENY | 89% Closely correlated | +1.95% | ||
COP - FENY | 89% Closely correlated | +2.38% | ||
PR - FENY | 88% Closely correlated | +2.07% | ||
More |